Zobrazeno 1 - 10
of 17
pro vyhledávání: '"JJ Ramos-Báez"'
Autor:
M Serrano Fuentes, M Lubillo Martell, JJ Ramos Báez, M Amat López, JJ Diaz Diaz, Mdc Salazar Dominguez, G Herrera Ortega, María Victoria, M Piñero González, SM Marrero Penichet
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Special drug prescriptions and authorisation by the hospital medical director is a necessary but time consuming activity that could even delay the start of treatment in some cases. To avoid documents and improve traceability
Autor:
M Perez-Perez, JJ Ramos-Báez, F Tellez-Perez, E Marquez-Fernandez, E Campos-Davila, P Villanueva, D Guerra-Estevez
Publikováno v:
European Journal of Hospital Pharmacy. 23:A42.2-A43
Background When both HIV and hepatitis C virus (HCV) treatments are indicated, the antiretroviral therapy (ART) may need to be modified before HCV treatment is initiated to reduce the potential for drug-drug interactions and overlapping toxicities th
Autor:
D Guerra Estévez, JJ Ramos-Báez, E Campos-Davila, F Araujo-Rodríguez, JC Roldán, E Marquez-Fernandez
Publikováno v:
European Journal of Hospital Pharmacy. 22:A185.2-A185
Background Our Healthcare Area is implementing Medicines Reconciliation (MedRec) supported by The European Union Network for Patient Safety and Quality of Care. In a situation of limited human resources, computerised MedRec tools could help introduce
Autor:
E Campos-Davila, J Roldán-Morales, J.L. Puerto-Alonso, D Guerra Estévez, JJ Ramos-Báez, F Araujo-Rodríguez
Publikováno v:
European Journal of Hospital Pharmacy. 22:A83.2-A83
Background Our Public Healthcare Service have developed some quality indicators (QI) based on the selection of drugs that support better evidence of efficiency in areas of prescribing where more deviations were detected in the past. Purpose To descri
Autor:
M Pérez León, JJ Ramos Báez, M Amat López, SM Marrero Penichet, R Molero Gómez, S González Munguía, G Herrera Ortega, N Sangil Monroy, V Morales León
Publikováno v:
European Journal of Hospital Pharmacy. 22:A64.2-A64
Background Inappropriate use of antibiotics has become a serious problem in the hospital setting. We implemented a stewardship programme in order to optimise antimicrobial treatment at our hospital. Purpose To analyse the contribution of an antibioti
Autor:
D Guerra Estévez, JC Roldán, E Campos-Davila, E Marquez-Fernandez, JJ Ramos-Báez, B Marmesat Rodas
Publikováno v:
European Journal of Hospital Pharmacy. 22:A54.1-A54
Background Pharmacists prescribe and monitor, in consensus with Oncology, individualised Post-Chemotherapy antiemetic regimes for all patients in our Hospital. Purpose To evaluate the quality and the acceptance of the antiemetic treatment prescribed
Autor:
E Campos-Davila, D Guerra-Estevez, E Marquez-Fernandez, G. Perez-Vazquez, JJ Ramos-Báez, J.L. Puerto-Alonso
Publikováno v:
European Journal of Hospital Pharmacy. 21:A145.3-A146
Background An association between sitagliptin and myopathy is exceptional, although four cases of rhabdomyolysis caused by a statin-sitagliptin interaction have been already reported, one of them with atorvastatin. Purpose To present a case of rhabdo
Autor:
JJ Ramos-Báez, E Campos-Davila, JL Prieto-García, F Tellez-Perez, D Guerra-Estevez, E Marquez-Fernandez
Publikováno v:
European Journal of Hospital Pharmacy. 21:A10.3-A11
Background In order to bring prescriptions for the use of direct-acting antiviral agents (DAAs) for the treatment of HCV genotype 1 infection in mono and co-infected patients in line with the recommendations of the Spanish Health System under the cur
Autor:
E Campos-Davila, G. Perez-Vazquez, D Guerra-Estevez, JJ Ramos-Báez, J.L. Puerto-Alonso, E Marquez-Fernandez
Publikováno v:
European Journal of Hospital Pharmacy. 21:A11.1-A11
Background According to current clinical guidelines developed from evidence-based medicine, heart failure with ventricular dysfunction needs to be treated with the combination of an ACE inhibitor and a beta blocker. An aldosterone antagonist should b
Autor:
G Herrera Ortega, MM Díaz Pestano, H Alonso Ramos, SM Marrero Penichet, M Amat López, ML Oliva Hernández, R Molero Gómez, M Pérez León, N Sangil Monroy, JJ Ramos Báez, S González Munguía
Publikováno v:
European Journal of Hospital Pharmacy. 21:A166.1-A166
Background Medicines reconciliation studies have produced estimates about rates of patients and drugs involved in unintended discrepancies along the reconciliation process, but to our knowledge no-one has worked out the reasons for these discrepancie